Individual protein analysis for NQO1, NRF1 and NRF2 and triple-negative phenotyping (NQO1−NRF1−NRF2−) failed to generate clinically-relevant high and low cut-offs, showing no significance in tumor cells. This evidence concerns the gene NFE2L2 and neoplasm.